Journal article
K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients
Cancer letters, v 115(1)
1997
PMID: 9097977
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Aberrant crypt foci (ACF) are microscopic lesions which can be detected, after methylene blue staining, in the overtly normal looking colonic mucosa of cancer patients. ACF have been postulated to be precursor lesions which develop into colorectal cancer. Mutations of
K-ras and
p53 are two important genetic events implicated in colon carcinogenesis. Mutations in
K-ras are detectable at earlier stages, while mutations in
p53 are detectable at later stages of colon carcinogenesis. Our objective was to compare the nature of genetic alterations in
K-ras (codon 12 and 13) and in
p53 (exon 4–9) between ACF and corresponding colonic tumors from cancer patients. ACF with ≥20 crypts/focus were harvested from overtly normal looking colonic mucosa of cancer patients at a distance of (approx.) 5 cm from the site of colonic tumors. The colonic tumors and ACF samples were compared for
K-ras codon 12 and 13 base pair sequence, using DNA sequencing and for
p53 (exon 5–9) allelic types, using PCR-SSCP and DNA sequencing. The results demonstrated a perfect correlation in terms of the type of
K-ras allele (wild or mutated) between the ACF (≥20 crypts/focus) and corresponding colonic tumors in
11
13
cancer patients. Analyses of
p53 mutations demonstrated the presence of
p53 mutations in colonic carcinomas from
10
13
patients. However,
p53 mutations could be detected in an ACF from only
1
13
patient. The results provides further evidence to the role of ACF as precursor to colon cancer. The presence of an identical
K-ras as well as
p53 mutation in an ACF and the corresponding colonic carcinoma in a patient suggests the possibility of existence of ACF that may be at a more advanced stage in the sequence of colonic tumorigenesis than others. In conclusion, the results suggest that a subset of ACF with higher multiplicity might be considered more likely to progress to more advanced lesions and should be explored as markers of colon cancer risk.
Metrics
Details
- Title
- K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients
- Creators
- N. Shivapurkar - Institute for Chemoprevention Research, Plano, TX 75093, USA.L. Huang - Allegheny University of the Health SciencesB. Ruggeri - Allegheny University of the Health SciencesP.A. Swalsky - University of PittsburghA. Bakker - University of PittsburghS. Finkelstein - University of PittsburghA. Frost - Washington University Medical CenterS. Silverberg - Washington University Medical Center
- Publication Details
- Cancer letters, v 115(1)
- Publisher
- Elsevier Ireland Ltd
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pathology (and Laboratory Medicine)
- Web of Science ID
- WOS:A1997WP88800006
- Scopus ID
- 2-s2.0-0031148556
- Other Identifier
- 991019167692604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Oncology